Literature DB >> 26968258

Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia.

Michelle R Iannacone1, Sudipta Sinnya2, Nirmala Pandeya3, Nikky Isbel4, Scott Campbell4, Jonathan Fawcett5, Peter H Soyer2, Lisa Ferguson1, Marcia Davis1, David C Whiteman1, Adèle C Green6.   

Abstract

The increased skin cancer incidence in organ transplant recipients is well-known, but the skin cancer burden at any one time is unknown. Our objective was to estimate the period prevalence of untreated skin malignancy and actinic keratoses in high-risk kidney and liver transplant recipients and to assess associated factors. Organ transplant recipients underwent full skin examinations by dermatologically trained physicians. The proportion of examined organ transplant recipients with histopathologically confirmed skin cancer in the 3-month baseline period was estimated. Prevalence ratios with 95% confidence intervals indicated significant associations. Of 495 high-risk organ transplant recipients (average age = 54 years, time immunosuppressed = 8.9 years), 135 (27%) had basal cell carcinoma, squamous cell carcinoma or Bowen's disease (intraepidermal carcinoma) present and confirmed in the baseline period, with respective prevalence proportions of 10%, 11%, and 18% in kidney transplant recipients and 10%, 9%, and 13% in liver transplant recipients. Over 80% had actinic keratosis present, with approximately 30% having 5 or more actinic keratoses. Organ transplant recipients with the highest skin cancer burden were Australian born, were fair skinned (prevalence ratio = 1.61, 95% confidence interval = [1.07, 2.43]), reported past skin cancer (prevalence ratio =3.39, 95% confidence interval = [1.93, 5.95]), and were receiving the most frequent skin checks (prevalence ratio = 1.76, 95% confidence interval = [1.15, 2.70]). In conclusion, high-risk organ transplant recipients carry a substantial measurable skin cancer burden at any given time and require frequent review through easily accessible, specialized services.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26968258     DOI: 10.1016/j.jid.2016.02.804

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Omega-3 fatty acid intake and decreased risk of skin cancer in organ transplant recipients.

Authors:  Kyoko Miura; Mandy Way; Zainab Jiyad; Louise Marquart; Elsemieke I Plasmeijer; Scott Campbell; Nicole Isbel; Jonathan Fawcett; Lisa E Ferguson; Marcia Davis; David C Whiteman; H Peter Soyer; Peter O'Rourke; Adèle C Green
Journal:  Eur J Nutr       Date:  2020-09-09       Impact factor: 5.614

2.  Skin conditions in liver transplant recipients in a Singapore academic medical center: A retrospective cohort study.

Authors:  Bertrand ShengYang Lian; Thinesh Lee Krishnamoorthy; Choon Chiat Oh
Journal:  JAAD Int       Date:  2021-07-31

Review 3.  [Actinic keratoses].

Authors:  T Hommel; R-M Szeimies
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

4.  Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).

Authors:  Nadja Angela Stenz; Susanne Stampf; Andreas W Arnold; Antonio Cozzio; Michael Dickenmann; Olivier Gaide; Mirjam Harms; Robert E Hunger; Emmanuel Laffitte; Michael Mühlstädt; Mirjam Nägeli; Günther F L Hofbauer
Journal:  Dermatology       Date:  2020-11-23       Impact factor: 5.366

5.  Web Application for the Automated Extraction of Diagnosis and Site From Pathology Reports for Keratinocyte Cancers.

Authors:  Bridie S Thompson; Sam Hardy; Nirmala Pandeya; Jean Claude Dusingize; Adele C Green; Athon Millane; Daniel Bourke; Ronald Grande; Cameron D Bean; Catherine M Olsen; David C Whiteman
Journal:  JCO Clin Cancer Inform       Date:  2020-08

6.  Pigmentary traits, sun exposure, and risk of non-Hodgkin's lymphoma/chronic lymphocytic leukemia: A study within the French E3N prospective cohort.

Authors:  Louis-Marie Garcin; Amandine Gelot; Roselyn-Rima Gomez; Gaëlle Gusto; Marie-Christine Boutron-Ruault; Marina Kvaskoff; Gianluca Severi; Caroline Besson
Journal:  Cancer Med       Date:  2020-11-21       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.